Esmolol

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1606 publications

Esmolol and Opioid Sparing: Analgesic Signal or Hemodynamic Silhouette?

Esmolol and Opioid Sparing: Analgesic Signal or Hemodynamic Silhouette?

Journal: Anesthesia and analgesia
Published: August 10, 2026

A scoping review of the evidence supporting antiarrhythmic use after paediatric cardiac surgery.

A scoping review of the evidence supporting antiarrhythmic use after paediatric cardiac surgery.

Journal: Cardiology in the young
Published: July 03, 2026

Tailored anesthesia protocols for echo-based HFpEF phenotyping in C57BL6/N mice.

Tailored anesthesia protocols for echo-based HFpEF phenotyping in C57BL6/N mice.

Journal: American journal of physiology. Heart and circulatory physiology
Published: June 29, 2026

Protective Effect of Esmolol on the Hypertensive Aortic Wall Persists After Withdrawal of Short-Term Treatment.

Protective Effect of Esmolol on the Hypertensive Aortic Wall Persists After Withdrawal of Short-Term Treatment.

Journal: Journal of clinical medicine
Published: June 19, 2026

Comparative Efficacy of Esmolol, Labetalol, and Lignocaine in Attenuating Hemodynamic Responses to Laryngoscopy and Intubation: A Randomized Double-Blind Study.

Comparative Efficacy of Esmolol, Labetalol, and Lignocaine in Attenuating Hemodynamic Responses to Laryngoscopy and Intubation: A Randomized Double-Blind Study.

Journal: Cureus
Published: June 10, 2026

Perioperative Esmolol Is Associated with Early Opioid Sparing in Patients with Ischemic Heart Disease: Evidence from a Retrospective Cohort and an Incisional Pain Rat Model.

Perioperative Esmolol Is Associated with Early Opioid Sparing in Patients with Ischemic Heart Disease: Evidence from a Retrospective Cohort and an Incisional Pain Rat Model.

Journal: Current medical science
Published: May 24, 2026

Statement of Retraction: Combined use of ultra-short acting β-blocker esmolol and intravenous phosphodiesterase 3 inhibitor enoximone.

Statement of Retraction: Combined use of ultra-short acting β-blocker esmolol and intravenous phosphodiesterase 3 inhibitor enoximone.

Journal: Expert opinion on pharmacotherapy
Published: May 08, 2026

Efficacy of Esmolol Versus Nitroglycerin in Maintaining the Quality of Bloodless Surgical Fields in Middle Ear Surgery: A Randomized Controlled Trial.

Efficacy of Esmolol Versus Nitroglycerin in Maintaining the Quality of Bloodless Surgical Fields in Middle Ear Surgery: A Randomized Controlled Trial.

Journal: Cureus
Published: May 05, 2026

Apathetic Thyroid Storm Presenting as New-Onset Dilated Cardiomyopathy and Cardiogenic Shock.

Apathetic Thyroid Storm Presenting as New-Onset Dilated Cardiomyopathy and Cardiogenic Shock.

Journal: Cureus
Published: May 03, 2026

Transesophageal echocardiography-guided anesthetic management of a patient with dilated cardiomyopathy, severe heart failure, and septic shock: a case report.

Transesophageal echocardiography-guided anesthetic management of a patient with dilated cardiomyopathy, severe heart failure, and septic shock: a case report.

Journal: Frontiers in medicine
Published: April 11, 2026

Efficacy and Safety of preoperative Controlling Heart Rate in Patients with Acute Type A Aortic Dissection (ESCORT): protocol for a randomised controlled trial.

Efficacy and Safety of preoperative Controlling Heart Rate in Patients with Acute Type A Aortic Dissection (ESCORT): protocol for a randomised controlled trial.

Journal: BMJ open
Published: April 10, 2026

Etripamil nasal spray (Cardamyst) for paroxysmal supraventricular tachycardia.

Etripamil nasal spray (Cardamyst) for paroxysmal supraventricular tachycardia.

Journal: The Medical letter on drugs and therapeutics
Published: April 10, 2026
Showing 1-12 of 1,606

Last Updated: 09/26/2026